Polycystic kidney disease is a genetic abnormality that causes multiple cysts to form on the kidneys and sometimes in other parts of the body. The disease has two classifications depending on the specifics of the transferability of the defective genes. Autosomal dominant polycystic kidney disease (ADPKD) is by far the more common form of the disorder, afflicting an estimated one to two in 1,000 live births. Autosomal dominance in a hereditary characteristic means that only one parent must have the gene in order to pass it on to offspring. The other form of polycystic kidney disease is autosomal recessive PKD (ARPKD). An autosomal recessive trait is one that requires genetic donations from both parents. ARPKD is found in only about 1 in 20,000 live births.
Most of the time (although not every time), ADPKD symptoms manifest in utero or very shortly after birth. The disorder results in cysts forming on the kidneys. Cysts are fluid-filled pockets of tissue. Simple kidney cysts are a common disorder especially in older people, are usually asymptomatic, and rarely present any serious complications. However, the cyst formation with ADPKD is different. The cysts are numerous and get progressively worse. They are accompanied by enlarged kidneys, often by pain in the kidney area and, over time, by impairment of renal function, leading in many cases to renal failure. PKD is the cause of approximately ten percent of cases of progressive renal failure requiring dialysis.
Cysts can also form on other organs as a result of ADPKD, including the liver, pancreas, spleen, brain, ovaries, prostate, cardiac valve, colon, and aorta. The symptoms of advanced ADPKD involve failure of function of any of these organs, most commonly the kidneys. These complications are potentially lethal, causing death by toxicity from failure of renal or hepatic function, or from a heart attack. Other complications include high blood pressure and increased frequency of urinary tract infections.
Diagnosis of ADPKD relies on family history, medical imaging, and genetic testing. Because of the autosomal dominant nature of the genetic disorder, it is almost always found in families; a dominant genetic trait cannot be a "sleeper" gene carried by a parent who does not manifest symptoms. In the case of ADPKD the picture is somewhat complicated by the fact that two different genetic anomalies are responsible for the condition, but more than 90 percent of patients with ADPKD have family members also exhibiting the trait. A history of ADPKD in the family is a risk factor calling for monitoring.
Medical imaging can reveal enlargement and the formation of cysts on the kidneys, both of which are primary symptoms of ADPKD. A final confirmative diagnosis can be provided by a genetic assay to reveal the presence of the genetic causes of the disorder.
There is no cure for PKD, but treatments can relieve symptoms and extend life expectancy. Surgical treatments can reduce or drain the cysts and relieve pain. Pain medications can also help relieve the discomfort. Aggressive efforts to lower blood pressure can reduce or slow down progression towards end-stage progressive kidney failure. A vasopressin antagonist drug called Tolvaptan shows promise in testing as a treatment that may reduce cyst formation and retard progression towards kidney failure.
When the disease has progressed to renal failure, it is treated as with any other form of kidney failure, by dialysis or by a kidney transplant. Kidney transplant is a standard treatment for final-stage progressive kidney disease regardless of the cause, and with ADPKD has the added benefit that the transplanted kidney does not develop cysts.
About MeMy name is Neville Pettersson and kidneypedia is my site. I hope you find it useful. I try to keep it updated frequently. I’m just a regular guy, married with 2 kids. I’ve created this site to help people find good info about cold sores. You can follow me on Facebook, Twitter and Google+